Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis

Respiratory Research

Volumn 8, Issue , 2007, Pages

  Corvol, Harriet ^a,b,c   Nathan, Nadia ^a,b,c   Charlier, Celine ^a,b,c   Chadelat, Katarina ^a,b,c   Le Rouzic, Philippe ^a,b,c   Tabary, Olivier ^a,b,c   Fauroux, Brigitte ^a,b,c   Henrion Caude, Alexandra ^a,b,c   Feingold, Josue ^a,c   Boelle, Pierre Yves ^a,b,d   Clement, Annick ^a,b,c  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDODEOXYRIBONUCLEASE BCLI; GLUCOCORTICOID RECEPTOR; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CYSTIC FIBROSIS; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GRAM NEGATIVE INFECTION; HAPLOTYPE; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; MALE; MICROBIOLOGY; MULTICENTER STUDY; PATHOPHYSIOLOGY;

ADOLESCENT; CHILD; COHORT STUDIES; CYSTIC FIBROSIS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DISEASE PROGRESSION; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LUNG DISEASES; MALE; POLYMORPHISM, GENETIC; PSEUDOMONAS INFECTIONS; RECEPTORS, GLUCOCORTICOID; RESPIRATORY FUNCTION TESTS;

EID: 38949114985     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-8-88     Document Type: Article

References (45)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245(4922):1066-1073. 10.1126/science.2475911, 2475911.
2. Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004, 23(1):146-158. 10.1183/09031936.03.00057003, 14738247.
3. Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006, 173(5):475-482. 10.1164/rccm.200505-840OE, 16126935.
4. Rao S, Grigg J. New insights into pulmonary inflammation in cystic fibrosis. Arch Dis Child 2006, 91(9):786-788. 10.1136/adc.2004.069419, 16923862.
5. Corvol H, Fitting C, Chadelat K, Jacquot J, Tabary O, Boule M, Cavaillon JM, Clement A. Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2003, 284(6):L997-1003.
6. Chmiel JF, Davis PB. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?. Respir Res 2003, 4(1):8. 203156, 14511398, 10.1186/1465-9921-4-8.
7. Koehler DR, Downey GP, Sweezey NB, Tanswell AK, Hu J. Lung inflammation as a therapeutic target in cystic fibrosis. Am J Respir Cell Mol Biol 2004, 31(4):377-381. 10.1165/rcmb.2004-0124TR, 15381503.
8. Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr 1995, 126(4):515-523. 10.1016/S0022-3476(95)70343-8, 7699528.
9. Cheng K, Ashby D, Smyth R. Oral steroids for cystic fibrosis. Cochrane Database Syst Rev 2000, CD000407.
10. Rosenstein BJ, Eigen H. Risks of alternate-day prednisone in patients with cystic fibrosis. Pediatrics 1991, 87(2):245-246.
11. Dezateux C, Walters S, Balfour-Lynn I. Inhaled corticosteroids for cystic fibrosis. Cochrane Database Syst Rev 2000, CD001915.
12. Balfour-Lynn IM, Klein NJ, Dinwiddie R. Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis. Arch Dis Child 1997, 77(2):124-130.
13. Bisgaard H, Pedersen SS, Nielsen KG, Skov M, Laursen EM, Kronborg G, Reimert CM, Hoiby N, Koch C. Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Psuedomonas aeruginosa infection. Am J Respir Crit Care Med 1997, 156(4 Pt 1):1190-1196.
14. Balfour-Lynn IM, Lees B, Hall P, Phillips G, Khan M, Flather M, Elborn JS. Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis. Am J Respir Crit Care Med 2006, 173(12):1356-1362. 10.1164/rccm.200511-1808OC, 16556691.
15. Drazen JM, Silverman EK, Lee TH. Heterogeneity of therapeutic responses in asthma. Br Med Bull 2000, 56(4):1054-1070. 10.1258/0007142001903535, 11359637.
16. Stevens A, Ray DW, Zeggini E, John S, Richards HL, Griffiths CE, Donn R. Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J Clin Endocrinol Metab 2004, 89(2):892-897. 10.1210/jc.2003-031235, 14764810.
17. Cutting GR. Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet 2005, 6:237-260. 10.1146/annurev.genom.6.080604.162254, 16124861.
18. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005, 353(14):1443-1453. 10.1056/NEJMoa051469, 16207846.
19. Yarden J, Radojkovic D, De Boeck K, Macek M, Zemkova D, Vavrova V, Vlietinck R, Cassiman JJ, Cuppens H. Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype. Thorax 2005, 60(4):320-325. 10.1136/thx.2004.025262, 15790988.
20. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH, Lamberts SW. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998, 83(1):144-151. 10.1210/jc.83.1.144, 9435432.
21. van Rossum EF, Koper JW, Huizenga NA, Uitterlinden AG, Janssen JA, Brinkmann AO, Grobbee DE, de Jong FH, van Duyn CM, Pols HA, Lamberts SW. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 2002, 51(10):3128-3134. 10.2337/diabetes.51.10.3128, 12351458.
22. van Rossum EF, Koper JW, van den Beld AW, Uitterlinden AG, Arp P, Ester W, Janssen JA, Brinkmann AO, de Jong FH, Grobbee DE, Pols HA, Lamberts SW. Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin Endocrinol (Oxf) 2003, 59(5):585-592. 10.1046/j.1365-2265.2003.01888.x, 14616881.
23. Rosmond R, Chagnon YC, Chagnon M, Perusse L, Bouchard C, Bjorntorp P. A polymorphism of the 5'-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men. Metabolism 2000, 49(9):1197-1199. 10.1053/meta.2000.7712, 11016903.
24. Coates AL, Desmond KJ, Demizio D, Allen PD. Sources of variation in FEV1. Am J Respir Crit Care Med 1994, 149(2 Pt 1):439-443.
25. Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1985, 727:1-113.
26. Lewontin RC. The Interaction of Selection and Linkage. Ii. Optimum Models. Genetics 1964, 50:757-782. 1210693, 14221879.
27. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995, 12(5):921-927.
28. Westfall PH, Young SS. Resampling-based multiple testing: examples and methods for P-value adjustment. John Wiley & Sons, Inc, New York 1993,
29. van Rossum EF, Voorhoeve PG, te Velde SJ, Koper JW, Delemarre-van de Waal HA, Kemper HC, Lamberts SW. The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J Clin Endocrinol Metab 2004, 89(8):4004-4009. 10.1210/jc.2003-031422, 15292341.
30. van Rossum EF, Roks PH, de Jong FH, Brinkmann AO, Pols HA, Koper JW, Lamberts SW. Characterization of a promoter polymorphism in the glucocorticoid receptor gene and its relationship to three other polymorphisms. Clin Endocrinol (Oxf) 2004, 61(5):573-581. 10.1111/j.1365-2265.2004.02132.x, 15521959.
31. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med 2005, 353(16):1711-1723. 10.1056/NEJMra050541, 16236742.
32. Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J 2006, 27(2):413-426. 10.1183/09031936.06.00125404, 16452600.
33. Zhou J, Cidlowski JA. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 2005, 70(5-7):407-417. 10.1016/j.steroids.2005.02.006, 15862824.
34. van Rossum EF, Feelders RA, van den Beld AW, Uitterlinden AG, Janssen JA, Ester W, Brinkmann AO, Grobbee DE, de Jong FH, Pols HA, Koper JW, Lamberts SW. Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men. Am J Med 2004, 117(3):158-162. 10.1016/j.amjmed.2004.01.027, 15276593.
35. Di Blasio AM, van Rossum EF, Maestrini S, Berselli ME, Tagliaferri M, Podesta F, Koper JW, Liuzzi A, Lamberts SW. The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin Endocrinol (Oxf) 2003, 59(1):68-74. 10.1046/j.1365-2265.2003.01798.x, 12807506.
36. van Rossum EF, Lamberts SW. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 2004, 59:333-357. 10.1210/rp.59.1.333, 14749509.
37. Panarelli M, Holloway CD, Fraser R, Connell JM, Ingram MC, Anderson NH, Kenyon CJ. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab 1998, 83(6):1846-1852. 10.1210/jc.83.6.1846, 9626107.
38. Corrigan CJ, Bungre JK, Assoufi B, Cooper AE, Seddon H, Kay AB. Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents. Eur Respir J 1996, 9(10):2077-2086. 10.1183/09031936.96.09102077, 8902470.
39. Haczku A, Alexander A, Brown P, Assoufi B, Li B, Kay AB, Corrigan C. The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J Allergy Clin Immunol 1994, 93(2):510-519. 10.1016/0091-6749(94)90361-1, 8120277.
40. Hearing SD, Norman M, Probert CS, Haslam N, Dayan CM. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 1999, 45(3):382-388. 1727659, 10446106.
41. van den Akker EL, Russcher H, van Rossum EF, Brinkmann AO, de Jong FH, Hokken A, Pols HA, Koper JW, Lamberts SW. Glucocorticoid receptor polymorphism affects transrepression but not transactivation. J Clin Endocrinol Metab 2006, 91(7):2800-2803. 10.1210/jc.2005-2119, 16684836.
42. Davies JC, Turner MW, Klein N. Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles. Eur Respir J 2004, 24(5):798-804. 10.1183/09031936.04.00055404, 15516675.
43. Goleva E, Li LB, Eves PT, Strand MJ, Martin RJ, Leung DY. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 2006, 173(6):607-616. 10.1164/rccm.200507-1046OC, 16387802.
44. Pujols L, Xaubet A, Ramirez J, Mullol J, Roca-Ferrer J, Torrego A, Cidlowski JA, Picado C. Expression of glucocorticoid receptors alpha and beta in steroid sensitive and steroid insensitive interstitial lung diseases. Thorax 2004, 59(8):687-693. 10.1136/thx.2003.013268, 15282390.
45. Rosmond R, Chagnon YC, Holm G, Chagnon M, Perusse L, Lindell K, Carlsson B, Bouchard C, Bjorntorp P. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res 2000, 8(3):211-218.